Geojit Investments
Geojit Investments has appeared in 9 distinct RetailIntel stories between Jun 2026 and Sep 2026, most often under retail company and leadership.
Latest: European regulators flagged NAION, a rare vision-loss condition, as a potential semaglutide side effect (25 Sep 2026). Earlier, geojit Investments’ Gaurang Shah identifies Titan Company as a preferred gems and jewellery stock for the festive season, alongside Muthoot Finance and Manappuram Finance in gold loans, citing rising gold prices and (10 Sep 2026). Earlier, indian e-commerce enablement platform Shiprocket debuted at a 35% premium on NSE after its Rs 1,617 crore IPO was subscribed 102.28 times (19 Aug 2026).
Key figures reported: 35% premium on NSE (19 Aug 2026); Rs 131 NSE listing price (19 Aug 2026); 34% premium on BSE (19 Aug 2026).
Brands most often mentioned alongside Geojit Investments: Anand Rathi Wealth, UPI, Ashok Leyland, Axis Capital, CAMS, Eicher Motors.
- Stories on record: 9
- First seen 11 Jun 2026 · Latest 25 Sep 2026
- Themes: retail company, leadership
- Sources cited above: 25 Sep 2026 · 10 Sep 2026 · 19 Aug 2026
Latest signals mentioning Geojit Investments
- Eye-safety scrutiny of semaglutide could reshape India’s fast-growing GLP-1 market
- Titan flagged as festive-season jewellery pick amid sustained gold demand
- Shiprocket lists 35% above issue price after ₹1,617 crore IPO draws 102x subscription
- Tata Sons succession in focus as markets assess Chandrasekaran exit
- Geojit stays bullish on Tata Motors CV and commercial-vehicle peers
- Lenskart’s strong Q1 draws scrutiny over profit quality and sustainable growth
- Proposed UPI MDR could raise SIP payment costs above ₹2,000 threshold
- Proposed UPI MDR could squeeze mutual-fund distributor margins
- Gold's 14% slide from May highs squeezes Q1 FY26 margins for Indian jewellery retailers